Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Blueprint Medicines Corp (BPMC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Blueprint Medicines Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1597264.
Total stock buying since 2015: $2,599,104.
Total stock sales since 2015: $231,789,870.
Total stock option exercises since 2015: $26,716,096.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 119,647 | $11,488,778 | 25,002 | $951,077 |
| 2024 | 0 | $0 | 408,611 | $39,133,354 | 286,996 | $9,909,174 |
| 2023 | 0 | $0 | 141,187 | $7,784,005 | 94,629 | $1,126,801 |
| 2022 | 6,100 | $348,278 | 159,883 | $9,751,206 | 120,909 | $1,241,801 |
| 2021 | 10 | $826 | 192,834 | $19,436,304 | 179,740 | $3,196,055 |
| 2020 | 0 | $0 | 305,417 | $26,920,259 | 283,708 | $4,187,344 |
| 2019 | 0 | $0 | 264,867 | $22,903,303 | 243,844 | $3,021,582 |
| 2018 | 0 | $0 | 178,188 | $14,439,401 | 140,407 | $1,091,175 |
| 2017 | 0 | $0 | 1,340,641 | $52,437,727 | 116,029 | $1,958,925 |
| 2016 | 0 | $0 | 215,714 | $5,484,336 | 19,167 | $32,162 |
| 2015 | 125,000 | $2,250,000 | 1,064,767 | $22,011,197 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-09-17 | Lydon Nicholas | Sale | 500 | 80.00 | 40,000 |
| 2020-09-17 | Boral Anthony L. (Chief Medical Officer) | Sale | 23,136 | 80.00 | 1,850,880 |
| 2020-09-17 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 23,136 | 10.87 | 251,488 |
| 2020-08-19 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 74.97 | 1,499,400 |
| 2020-08-19 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 8.80 | 176,000 |
| 2020-08-17 | Hurley Ariel (Principal Accounting Officer) | Sale | 700 | 75.00 | 52,500 |
| 2020-08-17 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 700 | 1.87 | 1,309 |
| 2020-07-06 | Lydon Nicholas | Sale | 26,007 | 80.73 | 2,099,545 |
| 2020-07-02 | Lydon Nicholas (Director) | Sale | 2,825 | 80.13 | 226,367 |
| 2020-07-01 | Lydon Nicholas (Director) | Sale | 1,300 | 80.21 | 104,272 |
| 2020-06-23 | Lydon Nicholas | Sale | 400 | 80.00 | 32,000 |
| 2020-06-22 | Durso-bumpus Debra (Chief People Officer) | Sale | 2,300 | 80.07 | 184,160 |
| 2020-06-22 | Durso-bumpus Debra (Chief People Officer) | Option Ex | 2,300 | 36.05 | 82,915 |
| 2020-06-22 | Lydon Nicholas | Sale | 13,017 | 80.29 | 1,045,134 |
| 2020-06-19 | Dorsch Marion (Chief Scientific Officer) | Sale | 4,600 | 79.00 | 363,400 |
| 2020-06-19 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 4,600 | 37.11 | 170,706 |
| 2020-06-19 | Lydon Nicholas | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Demetri George | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Coats Lonnel | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Goldberg Mark Alan | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Rowland Charles A Jr | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Seely Lynn | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Borisy Alexis | Option Ex | 1,312 | .00 | 0 |
| 2020-06-19 | Lynch Daniel | Option Ex | 1,312 | .00 | 0 |
| 2020-06-18 | Durso-bumpus Debra (Chief People Officer) | Sale | 2,500 | 75.18 | 187,950 |
| 2020-06-18 | Durso-bumpus Debra (Chief People Officer) | Option Ex | 2,500 | 18.00 | 45,000 |
| 2020-06-09 | Hurley Ariel (Principal Accounting Officer) | Sale | 700 | 75.00 | 52,500 |
| 2020-06-09 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 700 | 1.87 | 1,309 |
| 2020-06-02 | Hurley Ariel (Principal Accounting Officer) | Sale | 235 | 66.03 | 15,517 |
| 2020-05-12 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 64.82 | 1,296,339 |
| 2020-05-12 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 8.80 | 176,000 |
| 2020-03-23 | Dorsch Marion (Chief Scientific Officer) | Sale | 1,214 | 53.36 | 64,782 |
| 2020-03-23 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 52.88 | 1,057,700 |
| 2020-03-23 | Albers Jeffrey W. (CEO and President) | Option Ex | 40,000 | 4.18 | 167,200 |
| 2020-03-09 | Durso-bumpus Debra (Chief People Officer) | Sale | 432 | 51.94 | 22,438 |
| 2020-03-09 | Hurley Ariel (Principal Accounting Officer) | Sale | 253 | 51.94 | 13,140 |
| 2020-03-09 | Rossi Christina (Chief Commercial Officer) | Sale | 135 | 51.96 | 7,014 |
| 2020-03-09 | Murray Christopher K. (SVP, Technical Operations) | Sale | 402 | 51.94 | 20,879 |
| 2020-03-09 | Dorsch Marion (Chief Scientific Officer) | Sale | 536 | 51.99 | 27,866 |
| 2020-03-09 | Mccain Tracey L (EVP and Chief Legal Officer) | Sale | 617 | 51.98 | 32,071 |
| 2020-03-09 | Haviland Kate (Chief Operating Officer) | Sale | 671 | 51.98 | 34,878 |
| 2020-03-09 | Landsittel Michael (Chief Financial Officer) | Sale | 400 | 51.97 | 20,788 |
| 2020-03-09 | Albers Jeffrey W. (CEO and President) | Sale | 2,277 | 51.97 | 118,335 |
| 2020-03-09 | Boral Anthony L. (Chief Medical Officer) | Sale | 536 | 51.97 | 27,855 |
| 2020-03-03 | Haviland Kate (Chief Operating Officer) | Option Ex | 4,644 | 16.28 | 75,604 |
| 2020-01-10 | Haviland Kate (Chief Operating Officer) | Sale | 7,763 | 85.16 | 661,097 |
| 2020-01-10 | Haviland Kate (Chief Operating Officer) | Option Ex | 7,763 | 16.28 | 126,381 |
| 2020-01-10 | Demetri George | Sale | 568 | 85.00 | 48,280 |
| 2020-01-07 | Demetri George | Sale | 1,705 | 80.59 | 137,405 |
| 2019-12-19 | Dorsch Marion (Chief Scientific Officer) | Sale | 4,600 | 79.00 | 363,400 |
| 2019-12-19 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 4,600 | 37.11 | 170,706 |
| 2019-12-17 | Boral Anthony L. (Chief Medical Officer) | Sale | 10,000 | 76.49 | 764,900 |
| 2019-12-17 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 10,000 | 8.80 | 88,000 |
| 2019-12-16 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 75.00 | 31,125 |
| 2019-12-16 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-12-04 | Hurley Ariel (Principal Accounting Officer) | Sale | 192 | 77.25 | 14,832 |
| 2019-11-18 | Albers Jeffrey W. (CEO and President) | Sale | 8,256 | 75.76 | 625,474 |
| 2019-11-18 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 5.33 | 106,700 |
| 2019-11-15 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 75.00 | 31,125 |
| 2019-11-15 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-11-08 | Albers Jeffrey W. (CEO and President) | Sale | 11,744 | 74.56 | 875,632 |
| 2019-11-01 | Rossi Christina (Chief Commercial Officer) | Option Ex | 1,125 | .00 | 0 |
| 2019-10-30 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2019-10-17 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 75.00 | 31,125 |
| 2019-10-17 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-09-16 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 78.14 | 32,428 |
| 2019-09-16 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-08-21 | Boral Anthony L. (Chief Medical Officer) | Sale | 8,700 | 80.01 | 696,087 |
| 2019-08-21 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 8,700 | 8.80 | 76,560 |
| 2019-08-20 | Boral Anthony L. (Chief Medical Officer) | Sale | 1,300 | 80.44 | 104,572 |
| 2019-08-20 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 1,300 | 8.80 | 11,440 |
| 2019-08-19 | Haviland Kate (Chief Operating Officer) | Sale | 95 | 85.00 | 8,075 |
| 2019-08-19 | Haviland Kate (Chief Operating Officer) | Option Ex | 95 | 16.28 | 1,546 |
| 2019-08-19 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 83.24 | 1,664,800 |
| 2019-08-19 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2019-08-15 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 84.02 | 34,868 |
| 2019-08-15 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-08-15 | Coats Lonnel | Sale | 10,000 | 82.55 | 825,470 |
| 2019-08-15 | Coats Lonnel | Option Ex | 10,000 | 15.01 | 150,100 |
| 2019-07-19 | Hurley Ariel (Principal Accounting Officer) | Sale | 115 | 100.00 | 11,500 |
| 2019-07-19 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 115 | 8.80 | 1,012 |
| 2019-07-16 | Haviland Kate (Chief Operating Officer) | Sale | 1,571 | 95.31 | 149,739 |
| 2019-07-16 | Haviland Kate (Chief Operating Officer) | Option Ex | 11,562 | 16.28 | 188,229 |
| 2019-07-15 | Hurley Ariel (Principal Accounting Officer) | Sale | 830 | 94.98 | 78,833 |
| 2019-07-15 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 830 | 1.87 | 1,552 |
| 2019-07-08 | Boral Anthony L. (Chief Medical Officer) | Sale | 10,000 | 93.51 | 935,100 |
| 2019-07-08 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 10,000 | 8.80 | 88,000 |
| 2019-06-27 | Borisy Alexis | Sale | 21,818 | 91.79 | 2,002,674 |
| 2019-06-27 | Borisy Alexis | Option Ex | 21,818 | 32.77 | 715,084 |
| 2019-06-20 | Rowland Charles A Jr | Sale | 11,818 | 95.87 | 1,132,956 |
| 2019-06-20 | Rowland Charles A Jr | Option Ex | 11,818 | 9.46 | 111,798 |
| 2019-06-17 | Hurley Ariel (Principal Accounting Officer) | Sale | 1,405 | 98.50 | 138,385 |
| 2019-06-17 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 1,405 | 5.33 | 7,495 |
| 2019-06-17 | Dorsch Marion (Chief Scientific Officer) | Sale | 4,600 | 99.00 | 455,400 |
| 2019-06-17 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 4,600 | 37.11 | 170,706 |
| 2019-06-17 | Haviland Kate (Chief Operating Officer) | Sale | 11,952 | 97.06 | 1,160,061 |
| 2019-06-17 | Haviland Kate (Chief Operating Officer) | Option Ex | 11,952 | 26.16 | 312,724 |
| 2019-06-17 | Demetri George | Sale | 1,136 | 98.50 | 111,890 |
| 2019-06-17 | Albers Jeffrey W. (CEO and President) | Sale | 5,000 | 99.06 | 495,300 |
| 2019-06-17 | Albers Jeffrey W. (CEO and President) | Option Ex | 5,000 | 1.87 | 9,350 |
| 2019-06-13 | Hurley Ariel (Principal Accounting Officer) | Sale | 1,660 | 90.00 | 149,400 |
| 2019-06-13 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 1,660 | 1.87 | 3,104 |
| 2019-06-13 | Lydon Nicholas | Sale | 25,000 | 90.36 | 2,259,000 |
| 2019-06-13 | Demetri George | Sale | 568 | 90.00 | 51,120 |
| 2019-06-12 | Hurley Ariel (Principal Accounting Officer) | Sale | 1,073 | 85.00 | 91,205 |
| 2019-06-12 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 830 | 1.87 | 1,552 |
| 2019-06-12 | Lydon Nicholas | Sale | 25,000 | 83.73 | 2,093,250 |
| 2019-06-12 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 84.13 | 1,682,560 |
| 2019-06-12 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2019-03-15 | Hurley Ariel (Principal Accounting Officer) | Sale | 415 | 85.55 | 35,503 |
| 2019-03-15 | Hurley Ariel (Principal Accounting Officer) | Option Ex | 415 | 1.87 | 776 |
| 2019-03-15 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 86.49 | 1,729,740 |
| 2019-03-15 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2019-03-04 | Dorsch Marion (Chief Scientific Officer) | Sale | 2,300 | 84.76 | 194,952 |
| 2019-03-04 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 2,300 | 37.11 | 85,353 |
| 2019-03-01 | Haviland Kate (Chief Operating Officer) | Sale | 21,644 | 85.05 | 1,840,822 |
| 2019-03-01 | Haviland Kate (Chief Operating Officer) | Option Ex | 21,644 | 26.16 | 566,315 |
| 2018-11-19 | Albers Jeffrey W. (CEO and President) | Option Ex | 28,961 | 1.87 | 54,157 |
| 2018-11-05 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 63.92 | 1,278,360 |
| 2018-11-05 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2018-09-17 | Dorsch Marion (Chief Scientific Officer) | Sale | 2,300 | 71.21 | 163,789 |
| 2018-09-17 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 2,300 | 37.11 | 85,353 |
| 2018-08-06 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 69.95 | 1,399,100 |
| 2018-08-06 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2018-05-07 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 78.86 | 1,577,100 |
| 2018-05-07 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2018-03-19 | Demetri George | Sale | 5,492 | 99.99 | 549,161 |
| 2018-03-16 | Haviland Kate (Chief Business Officer) | Sale | 4,071 | 100.68 | 409,876 |
| 2018-03-16 | Haviland Kate (Chief Business Officer) | Option Ex | 4,071 | 26.16 | 106,517 |
| 2018-03-15 | Dorsch Marion (Chief Scientific Officer) | Sale | 2,300 | 100.07 | 230,160 |
| 2018-03-15 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 2,300 | 37.11 | 85,353 |
| 2018-03-02 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 91.55 | 1,831,020 |
| 2018-03-02 | Albers Jeffrey W. (CEO and President) | Option Ex | 20,000 | 1.87 | 37,400 |
| 2018-03-01 | Haviland Kate (Chief Business Officer) | Sale | 2,800 | 90.00 | 252,000 |
| 2018-03-01 | Haviland Kate (Chief Business Officer) | Option Ex | 2,800 | 36.05 | 100,939 |
| 2018-02-28 | Lydon Nicholas | Sale | 25,000 | 87.62 | 2,190,625 |
| 2018-02-27 | Mccain Tracey L (EVP and Chief Legal Officer) | Sale | 10,000 | 88.95 | 889,470 |
| 2018-02-27 | Mccain Tracey L (EVP and Chief Legal Officer) | Option Ex | 10,000 | 28.36 | 283,600 |
| 2018-02-27 | Haviland Kate (Chief Business Officer) | Sale | 3,200 | 89.05 | 284,953 |
| 2018-02-27 | Haviland Kate (Chief Business Officer) | Option Ex | 3,200 | 36.05 | 115,359 |
| 2018-02-27 | Demetri George | Sale | 6,250 | 89.11 | 556,968 |
| 2018-02-14 | Lynch Daniel | Sale | 12,500 | 80.42 | 1,005,250 |
| 2018-02-12 | Haviland Kate (Chief Business Officer) | Sale | 6,775 | 74.69 | 506,024 |
| 2018-02-12 | Haviland Kate (Chief Business Officer) | Option Ex | 6,775 | 16.28 | 110,297 |
| 2018-02-12 | Lynch Daniel | Sale | 17,500 | 75.17 | 1,315,545 |
| 2017-11-22 | Dorsch Marion (Chief Scientific Officer) | Sale | 9,166 | 70.00 | 641,620 |
| 2017-11-22 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 9,166 | 37.11 | 340,150 |
| 2017-11-21 | Dorsch Marion (Chief Scientific Officer) | Sale | 18,334 | 65.56 | 1,201,885 |
| 2017-11-21 | Dorsch Marion (Chief Scientific Officer) | Option Ex | 18,334 | 37.11 | 680,374 |
| 2017-11-21 | Haviland Kate (Chief Business Officer) | Option Ex | 5,874 | 16.28 | 95,628 |
| 2017-11-15 | Lynch Daniel | Sale | 5,000 | 63.33 | 316,650 |
| 2017-11-06 | Albers Jeffrey W. (CEO and President) | Sale | 30,000 | 71.26 | 2,137,800 |
| 2017-11-06 | Albers Jeffrey W. (CEO and President) | Option Ex | 24,514 | 1.87 | 45,841 |
| 2017-11-06 | Boral Anthony L. (Chief Medical Officer) | Sale | 5,000 | 71.69 | 358,440 |
| 2017-11-06 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 5,000 | 8.80 | 44,000 |
| 2017-10-05 | Haviland Kate (Chief Business Officer) | Sale | 5,449 | 66.45 | 362,102 |
| 2017-10-05 | Haviland Kate (Chief Business Officer) | Option Ex | 5,449 | 16.28 | 88,709 |
| 2017-09-18 | Haviland Kate (Chief Business Officer) | Sale | 6,356 | 60.03 | 381,550 |
| 2017-09-18 | Haviland Kate (Chief Business Officer) | Option Ex | 6,356 | 16.28 | 103,475 |
| 2017-09-18 | Lynch Daniel | Sale | 2,500 | 60.00 | 150,000 |
| 2017-08-09 | Boral Anthony L. (Chief Medical Officer) | Sale | 5,000 | 48.43 | 242,165 |
| 2017-08-09 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 5,000 | 8.80 | 44,000 |
| 2017-08-08 | Albers Jeffrey W. (CEO and President) | Sale | 10,000 | 50.70 | 507,000 |
| 2017-08-07 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 48.75 | 975,000 |
| 2017-07-05 | Haviland Kate (Chief Business Officer) | Sale | 7,265 | 53.65 | 389,781 |
| 2017-07-05 | Haviland Kate (Chief Business Officer) | Option Ex | 7,265 | 16.28 | 118,274 |
| 2017-07-05 | Lynch Daniel | Sale | 7,500 | 55.06 | 412,950 |
| 2017-06-28 | Haviland Kate (Chief Business Officer) | Sale | 6,357 | 50.00 | 317,850 |
| 2017-06-28 | Haviland Kate (Chief Business Officer) | Option Ex | 6,357 | 16.28 | 103,491 |
| 2017-06-28 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 50.18 | 1,003,540 |
| 2017-06-28 | Boral Anthony L. (Chief Medical Officer) | Sale | 10,000 | 50.11 | 501,130 |
| 2017-06-28 | Boral Anthony L. (Chief Medical Officer) | Option Ex | 10,000 | 8.80 | 88,000 |
| 2017-06-28 | Lynch Daniel | Sale | 32,500 | 50.13 | 1,629,127 |
| 2017-03-16 | Levin Mark J (10% Owner) | Sale | 30,000 | 41.15 | 1,234,350 |
| 2017-03-14 | Haviland Kate (Chief Business Officer) | Sale | 12,714 | 40.01 | 508,687 |
| 2017-03-14 | Haviland Kate (Chief Business Officer) | Option Ex | 12,714 | 16.28 | 206,983 |
| 2017-03-14 | Lydon Nicholas | Sale | 70,000 | 39.89 | 2,792,300 |
| 2017-03-14 | Albers Jeffrey W. (CEO and President) | Sale | 20,000 | 39.90 | 797,900 |
| 2017-03-14 | Lynch Daniel | Sale | 7,500 | 40.12 | 300,900 |
| 2017-02-07 | Tepper Robert I (10% Owner) | Sale | 1,000,000 | 35.27 | 35,275,000 |
| 2016-12-19 | Starr Kevin P (10% Owner) | Sale | 106,489 | 28.19 | 3,002,350 |
| 2016-11-01 | Lynch Daniel | Sale | 1,700 | 30.04 | 51,068 |
| 2016-10-13 | Lynch Daniel | Sale | 21,800 | 30.02 | 654,436 |
| 2016-08-08 | Albers Jeffrey W. (CEO and President) | Sale | 17,000 | 23.03 | 391,510 |
| 2016-06-03 | Albers Jeffrey W. (CEO and President) | Sale | 17,000 | 20.03 | 340,510 |
| 2016-04-13 | Lengauer Christoph (Chief Scientific Officer) | Sale | 15,872 | 20.01 | 317,598 |
| 2016-04-12 | Lengauer Christoph (Chief Scientific Officer) | Sale | 10,316 | 20.01 | 206,423 |
| 2016-04-11 | Lengauer Christoph (Chief Scientific Officer) | Sale | 8,537 | 20.30 | 173,301 |
| 2016-04-06 | Albers Jeffrey W. (CEO and President) | Sale | 17,000 | 20.42 | 347,140 |
| 2016-03-24 | Lengauer Christoph (Chief Scientific Officer) | Option Ex | 19,167 | 1.68 | 32,162 |
| 2015-12-17 | Lengauer Christoph (Chief Scientific Officer) | Sale | 6,463 | 25.14 | 162,479 |
| 2015-12-16 | Lengauer Christoph (Chief Scientific Officer) | Sale | 24,156 | 25.03 | 604,624 |
| 2015-12-15 | Lengauer Christoph (Chief Scientific Officer) | Sale | 500 | 25.00 | 12,500 |
| 2015-11-27 | Fmr Llc (Other) | Sale | 57,819 | 21.91 | 1,267,103 |
| 2015-11-25 | Fmr Llc (Other) | Sale | 229,596 | 21.23 | 4,873,175 |
| 2015-11-24 | Fmr Llc (Other) | Sale | 161,271 | 20.14 | 3,247,997 |
| 2015-11-23 | Fmr Llc (Other) | Sale | 85,300 | 20.14 | 1,717,515 |
| 2015-11-20 | Fmr Llc (Other) | Sale | 104,272 | 20.09 | 2,095,345 |
| 2015-11-19 | Fmr Llc (Other) | Sale | 155,894 | 19.86 | 3,096,054 |
| 2015-11-18 | Fmr Llc (Other) | Sale | 81,324 | 19.76 | 1,607,206 |
| 2015-11-17 | Fmr Llc (Other) | Sale | 27,490 | 20.57 | 565,469 |
| 2015-11-16 | Fmr Llc (Other) | Sale | 28,684 | 21.25 | 609,391 |
| 2015-11-10 | Albers Jeffrey W. (CEO and President) | Sale | 7,000 | 21.87 | 153,090 |
| 2015-11-03 | Lengauer Christoph (Chief Scientific Officer) | Sale | 36,734 | 20.98 | 770,679 |
| 2015-11-02 | Albers Jeffrey W. (CEO and President) | Sale | 10,000 | 21.02 | 210,200 |
| 2015-11-02 | Lengauer Christoph (Chief Scientific Officer) | Sale | 48,264 | 21.10 | 1,018,370 |
| 2015-05-05 | Fmr Llc (Other) | Buy | 125,000 | 18.00 | 2,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BPMC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Blueprint Medicines Corp (symbol BPMC, CIK number 1597264) see the Securities and Exchange Commission (SEC) website.